These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1289513)

  • 21. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progressive renal failure. Why blood pressure must now be monitored].
    Tepel M; van der Giet M; Zidek W
    MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renally compromised older hypertensive: therapeutic considerations.
    Weder AB
    Geriatrics; 1991 Feb; 46(2):36-8, 43-8. PubMed ID: 1991620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiproteinuric effect of losartan is systemic blood pressure dependent.
    Crowe AV; Howse M; Vinjamuri S; Kemp GJ; Williams PS
    Nephrol Dial Transplant; 2003 Oct; 18(10):2160-4. PubMed ID: 13679496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypertension in patients with chronic renal disease].
    Laville M
    Rev Prat; 2004 Mar; 54(6):641-5. PubMed ID: 15222616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.
    Ruilope LM; Casal MC; Guerrero L; Alcázar JM; Férnandez ML; Lahera V; Rodicio JL
    Drugs; 1992; 44 Suppl 1():94-8. PubMed ID: 1283591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure.
    Schohn DC; Jahn HA; Maareck M
    Drugs; 1993; 46 Suppl 2():113-9; discussion 119-20. PubMed ID: 7512464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Verapamil toxicity: an unusual case report and review of the literature.
    Batalis NI; Harley RA; Schandl CA
    Am J Forensic Med Pathol; 2007 Jun; 28(2):137-40. PubMed ID: 17525564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Junctional bradycardia with verapamil in renal failure--care required even with mild hyperkalaemia.
    Hegazi MO; Aldabie G; Al-Mutairi S; El Sayed A
    J Clin Pharm Ther; 2012 Dec; 37(6):726-8. PubMed ID: 22568727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive activity of verapamil: impact of dietary sodium. The VERSAL Study Group.
    Redón-Más J; Abellán-Alemán J; Aranda-Lara P; de la Figuera-von Wichmann M; Luque-Otero M; Rodicio-Díaz JL; Ruilope-Urioste LM; Velasco-Quintana J
    J Hypertens; 1993 Jun; 11(6):665-71. PubMed ID: 8397246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.
    August P; Lenz T; Laragh JH
    Am J Hypertens; 1993 Apr; 6(4):148S-154S. PubMed ID: 8389563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension and the kidney.
    Krzesinski JM; Cohen EP
    Acta Clin Belg; 2007; 62(1):5-14. PubMed ID: 17451140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antihypertensive effect of verapamil at extremes of dietary sodium intake.
    Nicholson JP; Resnick LM; Laragh JH
    Ann Intern Med; 1987 Sep; 107(3):329-34. PubMed ID: 3619222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of the progression of chronic kidney failure].
    Teschner M; Bahner U; Heidland A
    Dtsch Med Wochenschr; 1987 Feb; 112(9):353-8. PubMed ID: 3545754
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative studies with propranolol, verapamil and atenolol in hypertensive dialysis patients].
    Hepp A; Maisch B; Raff U; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():239. PubMed ID: 613588
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship between proteinuria and response to low protein diets early in chronic renal failure.
    Rosman JB; ter Wee PM
    Blood Purif; 1989; 7(1):52-7. PubMed ID: 2645924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Control of drug resistant arterial hypertension before the stage of terminal chronic kidney failure by a weekly session of hemofiltration].
    Elsener M; Di-Falco F; Vialtel P; Cordonnier D; Meftahi H; Denis MC
    Nouv Presse Med; 1979 Feb; 8(9):698-9. PubMed ID: 450686
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of calcium channel blockers in protection against experimental renal injury.
    Schrier RW
    Am J Med; 1991 May; 90(5A):21S-26S. PubMed ID: 2039016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interrelationship in humans between sodium intake and hypertension.
    Morgan T; Carney S; Wilson M
    Clin Exp Pharmacol Physiol; 1975; Suppl 2():127-9. PubMed ID: 1183079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.